First-line Systemic Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer: Bevacizumab Treatment: Guideline Recommendations

Evidence-Based Series #7-10 Version 2.2010: Section 1
First-line Systemic Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer: Bevacizumab Treatment: Guideline Recommendations
J. Goffin, N, Coakley, C. Lacchetti, P.M. Ellis, Y.C. Ung, W.K. Evans,
and the Lung Cancer Disease Site Group (DSG)

A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO)

The guideline recommendations contained in Section 1 of this Evidence-based Series replace recommendations in previous versions of guideline #7-10. These updated recommendations are based on a new systematic review of the relevant data from January 2007 to October 2009 (Section 2A) plus the original evidence up to July 2005 (Section 2B).

Current Report Date: February 3, 2010
Original Report Date: May 22, 2009

open here to see the full-text: [pdf, 10 pages]
http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=45735